Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

118.82
Delayed Data
As of Jan 17
 -0.52 / -0.44%
Today’s Change
65.81
Today|||52-Week Range
125.72
+3.17%
Year-to-Date
Why Alnylam Pharmaceuticals Rose 57.9% in 2019
Jan 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close119.34
Today’s open119.01
Day’s range116.16 - 119.46
Volume860,384
Average volume (3 months)701,765
Market cap$13.3B
Data as of 4:00pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)-39.67%
Earnings growth (this year)-4.42%
Earnings growth (next 5 years)+23.64%
Revenue growth (last year)-16.69%
P/E ratioNM
Price/Sales97.91
Price/Book9.24

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+1.54+0.68%
MYLMylan NV-0.31-1.41%
BHCValeant Pharmaceutic...+0.50+1.68%
SRPTSarepta Therapeutics...-2.40-1.84%
Data as of 6:30pm ET, 01/17/2020

Financials

Next reporting dateFebruary 6, 2020
EPS forecast (this quarter)-$2.22
Annual revenue (last year)$74.9M
Annual profit (last year)-$761.5M
Net profit margin-1,016.58%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts